Germany-based Bayer invests in increasing capacity at Guatemala plant. Regional market in medicines $1.3 billion

\ Bayer’s machines for making pills are increasingly faster and more efficient. The Germany-based pharmaceutical company is investing $5 million in raising production capacity at its plant in Guatemala.\ \ The investment will raise output by 15 percent, with a sixth production line.\ \ The Central American market in medicines is valued at $1.35 billion, of which Guatemala accounts for 26 percent.\ \ \ \ Original source (in Spanish): El Periódico\ \ \ \